Alzheimer’s Disease Diagnostics Market

Best Price Guarantee	Publisher	Published Date	SKU
from $3,475	Evolve Business Intelligence	April, 2025	EVBI19931980

Best Price Guarantee
Price	from $3,475
Publisher	Evolve Business Intelligence
Published Date	April, 2025
SKU	EVBI19931980

Table of Contents
Description

The Alzheimer's Disease Diagnostics Market is projected to reach USD 7.15 billion by 2033. In 2023, the market size was USD 4.14 billion, and it is anticipated to grow at a compound annual growth rate (CAGR) of 8.90% from 2023 to 2033. Diagnosing Alzheimer's disease involves a thorough evaluation of an individual's cognitive abilities, memory, behavior, and functional skills to identify the presence and progression of the condition. Diagnostic tools include cognitive tests, brain imaging (such as MRI or PET scans), medical history assessments, and evaluations of daily living activities. These tools help clinicians distinguish Alzheimer's disease from other types of dementia and detect characteristic brain changes like amyloid plaques and tau tangles. Early and accurate diagnosis is essential for initiating proper interventions and providing support to individuals and their families coping with this neurodegenerative disorder.

The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.

Segments covered

By Type (Nervous System, Examination, Genetic Testing, Minor Mental State Examination, Brain Imaging)
By Diagnostic Test (Genetic Testing, Positron Emission Tomography, Electroencephalography, Magnetic Resonance Imaging, Computed Tomography, Neurological Exam, Mini-mental State Exam (MMSE), Brain Imaging, Others)
By End User (Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, Academic Research Center)

Key players

Hoffmann-La Roche
Bristol-Myers Squibb
AstraZeneca PLC
Corium Inc
Eisai Co. Ltd
Biogen Inc
Johnson & Johnson
Eli Lilly and Company
Lupin Limited
AbbVie Inc

CHAPTER 1. Executive Summary: CHAPTER 2. Scope of the Study; 2.1. Market Definition; 2.2. Market Scope & Segmentation; 2.2.1. Objective of Report; CHAPTER 3. Evolve BI Methodology; 3.1. Data Collection & Validation Approach; 3.2. Market Size Estimation and Forecast; CHAPTER 4. Exclusive Analysis; 4.1. Market Opportunity Score; 4.1.1. Type Segement – Market Opportunity Score; 4.1.2. Diagnostic Test Segment – Market Opportunity Score; 4.1.3. End User Segment – Market Opportunity Score; 4.2. Key Market Influencing Indicators; CHAPTER 5. Market Insights and Trends; 5.1. Value Chain Analysis; 5.1.1. Raw Material; 5.1.2. Manufacturing Process; 5.1.3. Distribution Channel; 5.1.4. End User; 5.2. Porter’s Five Forces Analysis; 5.2.1. Bargaining Power of Buyers; 5.2.2. Bargaining Power of Suppliers; 5.2.3. Threat of New Entrant; 5.2.4. Threat of Substitute; 5.2.5. Industry Rivalry; 5.3. COVID-19 Impact and Post COVID Scenario on Alzheimers Disease Diagnostics Market; 5.3.1. Impact of COVID-19; 5.3.2. Government Support and Industry Revival Policies; 5.3.3. Measures Taken by Companies to Mitigate Negative Impact; 5.3.4. Post COVID Trend; CHAPTER 6. MArket Dynamics; 6.1. Introduction; 6.2. Drivers; 6.2.1. Driver 1; 6.2.2. Driver 2; 6.2.3. Driver 3; 6.3. Restraints; 6.3.1. Restraint 1; 6.3.2. Restraint 2; 6.4. Opportunity; 6.4.1. Opportunity 1; CHAPTER 7. Global Alzheimers Disease Diagnostics Market, By Type; 7.1. Introduction; 7.1.1. Nervous System; 7.1.2. Examination; 7.1.3. Genetic Testing; 7.1.4. Minor Mental State Examination; 7.1.5. Brain Imaging; CHAPTER 8. Global Alzheimers Disease Diagnostics Market, By Diagnostic Test; 8.1. Introduction; 8.1.1. Genetic Testing; 8.1.2. Positron Emission Tomography; 8.1.3. Electroencephalography; 8.1.4. Magnetic Resonance Imaging; 8.1.5. Computed Tomography; 8.1.6. Neurological Exam; 8.1.7. Mini-mental State Exam (MMSE); 8.1.8. Brain Imaging; 8.1.9. Others; CHAPTER 9. Global Alzheimers Disease Diagnostics Market, By End User; 9.1. Introduction; 9.1.1. Clinics; 9.1.2. Hospitals; 9.1.3. Diagnostic Centers; 9.1.4. Pharmaceutical Companies; 9.1.5. Academic Research Center; CHAPTER 10. Global Alzheimers Disease Diagnostics Market, By Region; 10.1. Introduction; 10.2. NORTH AMERICA; 10.2.1. North America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.2.2. North America: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.2.3. North America: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.2.4. North America: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.2.5. US; 10.2.5.1. US: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.2.5.2. US: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.2.5.3. US: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.2.6. CANADA; 10.2.6.1. Canada: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.2.6.2. Canada: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.2.6.3. Canada: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.2.7. MEXICO; 10.2.7.1. Mexico: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.2.7.2. Mexico: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.2.7.3. Mexico: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.3. Europe; 10.3.1. Europe: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.3.2. Europe: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.3.3. Europe: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.3.4. Europe: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.3.5. U.K.; 10.3.5.1. U.K.: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.3.5.2. U.K.: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.3.5.3. U.K.: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.3.6. GERMANY; 10.3.6.1. Germany: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.3.6.2. Germany: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.3.6.3. Germany: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.3.7. FRANCE; 10.3.7.1. France: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.3.7.2. France: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.3.7.3. France: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.3.8. ITALY; 10.3.8.1. Italy: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.3.8.2. Italy: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.3.8.3. Italy: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.3.9. SPAIN; 10.3.9.1. Spain: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.3.9.2. Spain: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.3.9.3. Spain: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.3.10. BENELUX; 10.3.10.1. BeNeLux: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.3.10.2. BeNeLux: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.3.10.3. BeNeLux: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.3.11. RUSSIA; 10.3.11.1. Russia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.3.11.2. Russia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.3.11.3. Russia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.3.12. REST OF EUROPE; 10.3.12.1. Rest of Europe: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.3.12.2. Rest of Europe: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.3.12.3. Rest of Europe: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.4. Asia Pacific; 10.4.1. Asia Pacific: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.4.2. Asia Pacific: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.4.3. Asia Pacific: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.4.4. Asia Pacific: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.4.5. CHINA; 10.4.5.1. China: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.4.5.2. China: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.4.5.3. China: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.4.6. JAPAN; 10.4.6.1. Japan: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.4.6.2. Japan: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.4.6.3. Japan: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.4.7. INDIA; 10.4.7.1. India: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.4.7.2. India: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.4.7.3. India: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.4.8. SOUTH KOREA; 10.4.8.1. South Korea: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.4.8.2. South Korea: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.4.8.3. South Korea: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.4.9. THAILAND; 10.4.9.1. Thailand: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.4.9.2. Thailand: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.4.9.3. Thailand: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.4.10. INDONESIA; 10.4.10.1. Indonesia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.4.10.2. Indonesia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.4.10.3. Indonesia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.4.11. MALAYSIA; 10.4.11.1. Malaysia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.4.11.2. Malaysia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.4.11.3. Malaysia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.4.12. AUSTRALIA; 10.4.12.1. Australia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.4.12.2. Australia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.4.12.3. Australia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.4.13. REST FO ASIA PACIFIC; 10.4.13.1. Rest fo Asia Pacific: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.4.13.2. Rest fo Asia Pacific: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.4.13.3. Rest fo Asia Pacific: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.5. South America; 10.5.1. South America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.5.2. South America: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.5.3. South America: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.5.4. South America: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.5.5. BRAZIL; 10.5.5.1. Brazil: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.5.5.2. Brazil: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.5.5.3. Brazil: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.5.6. ARGENTINA; 10.5.6.1. Argentina: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.5.6.2. Argentina: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.5.6.3. Argentina: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.5.7. REST OF SOUTH AMERICA; 10.5.7.1. Rest of South America: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.5.7.2. Rest of South America: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.5.7.3. Rest of South America: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.6. Middle East & Africa; 10.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2023 – 2033 ($ Million); 10.6.2. Middle East & Africa: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.6.3. Middle East & Africa: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.6.4. Middle East & Africa: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.6.5. SAUDI ARABIA; 10.6.5.1. Saudi Arabia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.6.5.2. Saudi Arabia: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.6.5.3. Saudi Arabia: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.6.6. UAE; 10.6.6.1. UAE: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.6.6.2. UAE: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.6.6.3. UAE: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.6.7. EGYPT; 10.6.7.1. Egypt: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.6.7.2. Egypt: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.6.7.3. Egypt: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.6.8. SOUTH AFRICA; 10.6.8.1. South Africa: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.6.8.2. South Africa: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.6.8.3. South Africa: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); 10.6.9. REST OF MIDDLE EAST & AFRICA; 10.6.9.1. Rest of Middle East & Africa: Market Size and Forecast, By Type, 2023 – 2033 ($ Million); 10.6.9.2. Rest of Middle East & Africa: Market Size and Forecast, By Diagnostic Test, 2023 – 2033 ($ Million); 10.6.9.3. Rest of Middle East & Africa: Market Size and Forecast, By End User, 2023 – 2033 ($ Million); CHAPTER 12. Competitive Landscape; 12.1. Competitior Benchmarking 2023; 12.2. Market Share Analysis; 12.3. Key Developments Analysis By Top 5 Companies; 12.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players; CHAPTER 13. Company Profiles; 13.1. F. Hoffmann-La Roche; 13.1.1. Business Overview; 13.1.2. Financial Analysis; 13.1.2.1. Business Segment Revenue, 2020, 2021, 2022, $ Million; 13.1.2.2. Geographic Revenue Mix, 2022 (% Share); 13.1.3. Product Portfolio; 13.1.4. Recent Development and Strategies Adopted; 13.1.5. SWOT Analysis; 13.2. Bristol-Myers Squibb; 13.3. AstraZeneca PLC; 13.4. Corium Inc; 13.5. Eisai Co. Ltd; 13.6. Biogen Inc; 13.7. Johnson & Johnson; 13.8. Eli Lilly and Company; 13.9. Lupin Limited; 13.10. AbbVie Inc